Your browser doesn't support javascript.
loading
Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial.
Kubasch, A S; Peterlin, P; Cluzeau, T; Götze, K S; Sockel, K; Teipel, R; Jentzsch, M; Attalah, H; Sebert, M; Chermat, F; Gloaguen, S; Puttrich, M; Cross, M; Schneider, M; Kayser, S; Schipp, D; Giagounidis, A; Tirado-Gonzalez, I; Descot, A; van de Loosdrecht, A; Weigert, A; Metzeler, K H; Fenaux, P; Medyouf, H; Platzbecker, U; Ades, L.
Afiliação
  • Kubasch AS; Department of Hematology, Hemostaseology, Cellular Therapy and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany.
  • Peterlin P; German MDS Study Group (D-MDS), Leipzig, Germany.
  • Cluzeau T; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.
  • Götze KS; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.
  • Sockel K; Service d'hématologie Clinique, CHU de Nantes, Nantes, France.
  • Teipel R; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.
  • Jentzsch M; CHU de Nice, Département d'Hématologie Clinique, Nice, France.
  • Attalah H; German MDS Study Group (D-MDS), Leipzig, Germany.
  • Sebert M; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.
  • Chermat F; Department of Medicine III, Klinikum rechts der Isar, TUM, Munich, Germany.
  • Gloaguen S; German MDS Study Group (D-MDS), Leipzig, Germany.
  • Puttrich M; Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany.
  • Cross M; Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany.
  • Schneider M; Department of Hematology, Hemostaseology, Cellular Therapy and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany.
  • Kayser S; Groupe Francophone des Myélodysplasies, Paris, France.
  • Schipp D; Groupe Francophone des Myélodysplasies, Paris, France.
  • Giagounidis A; Service d'Hématologie Seniors, Hopital Saint Louis, Assistance Publique-Hôpitaux de Paris and Paris Cité University, Paris, France.
  • Tirado-Gonzalez I; Groupe Francophone des Myélodysplasies, Paris, France.
  • Descot A; German MDS Study Group (D-MDS), Leipzig, Germany.
  • van de Loosdrecht A; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.
  • Weigert A; GWT-TUD GmbH, Dresden, Germany.
  • Metzeler KH; Department of Hematology, Hemostaseology, Cellular Therapy and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany.
  • Fenaux P; Department of Hematology, Hemostaseology, Cellular Therapy and Infectious Diseases, Leipzig University Hospital, Leipzig, Germany.
  • Medyouf H; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany.
  • Platzbecker U; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ades L; DS-Statistics, Rosenthal-Bielatal, Germany.
Leukemia ; 37(11): 2309-2313, 2023 11.
Article em En | MEDLINE | ID: mdl-37735558
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article